4-Hydroxyisoleucine-Loaded Nanogel: Development from an Optimized Nanoemulsion for Antidiabetic Therapy

This work focuses on the creation and assessment of a nanogel system produced from an optimal nanoemulsion formulation infused with 4-hydroxyisoleucine, a powerful antidiabetic bioactive agent. Diabetes mellitus affects 425 million people globally, with 82 million in Southeast Asia. The pandemic could lead to cardiovascular disorders, strokes, renal failures, and blindness. Fenugreek has anti-diabetic properties and reduced cholesterol levels in type II diabetes patients. Nanocarriers improve drug bioavailability. Method: Nanoemulsions were created with an aqueous titration emulsification technique and tailored according to droplet size, polydispersity index (PDI), zeta potential, and entrapment efficiency. The improved nanoemulsion demonstrated advantageous physicochemical characteristics, including nanoscale droplet dimensions and steady dispersion. The optimized nanoemulsion was integrated into a biocompatible gel matrix, resulting in a nanogel with improved stability and regulated drug release properties. The synthesized nanogel was assessed for rheological characteristics, pH, Spreadability, in vitro drug release, and ex vivo skin penetration. The results demonstrated a prolonged release profile and enhanced penetration efficiency, indicating increased transdermal administration of 4-hydroxyisoleucine. Conclusion: The research investigates the synthesis and characterisation of 4-hydroxy isoleucine (4HILCN), a medication of 99% purity. FTIR spectroscopy was used to identify and describe the medication, assess its purity, and conduct quantitative analysis. The medication was formulated using an optimum composition of three mixtures including oil and Smix and water. The nanoemulsion was transformed into a hydrogel for dermal application using Carbopol-934. The uniformity of the compositions remained stable after being transferred into flint-colored glass containers. The ideal pH range for cosmeceutical assessment is 5.0-6.0. Stability experiments indicated no any variation in parameters which are indicative of the instability. In vitro investigation of drug release kinetics shown enhanced solubility and diffusion rates. Ex-vivo permeation experiments demonstrated superior penetration of drug from 4HILCN-NG compared to Neat Formulation gel of drug and 4HILCN-NEO. The research indicates that the nanogel technology serves as a potential transdermal delivery system for Antidiabetic treatment, providing improved bioavailability and patient adherence.